Prilosec OTC “Coverage Gap” Pitch Spotlights Medicare Payment Question
This article was originally published in The Pink Sheet Daily
Executive Summary
Procter & Gamble supports initiative to provide advice on avoiding Part D “coverage gap” in Medicare benefit, including using Prilosec OTC instead of Rx products.
You may also be interested in...
Vaccination Health Next Stop For Dentovations’ Self+ Immunity Supplement Line
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.
Biotin And ‘Healthy Hair’: Federal Pre-emption Clips False Advertising Complaint In California
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.
While Opening Dietary Ingredient Portfolio Wider, DuPont Opens Door On Online Supply Store
In its “robust, holistic hub” online, firms in the VMS product supply chain can determine their needs, “by product, solution or delivery formats,” and use a “comprehensive and unique portfolio” to “turn natural sources into shelf-ready products.”
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: